Technical Analysis for VBLT - Vascular Biogenics Ltd.

Grade Last Price % Change Price Change
grade D 1.28 -1.54% -0.02
VBLT closed down 1.54 percent on Friday, May 24, 2019, on 7 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Up
See historical VBLT trend table...

Date Alert Name Type % Chg
20 DMA Support Bullish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
20 DMA Support Bullish -1.54%
Bollinger Band Squeeze Range Contraction -1.54%
Crossed Above 20 DMA Bullish -3.76%
Bollinger Band Squeeze Range Contraction -3.76%
20 DMA Resistance Bearish 2.40%
Bollinger Band Squeeze Range Contraction 2.40%
Stochastic Reached Oversold Weakness 2.40%
Oversold Stochastic Weakness 2.40%

Older signals for VBLT ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Vascular Biogenics Ltd., a clinical-stage biopharmaceutical company, is engaged in the discovery, development, and commercialization of treatments for cancer and immune-inflammatory diseases. Its lead product candidates include VB-111, a gene-based biologic, which is in Phase II clinical trials for the treatment of recurrent glioblastoma, an aggressive form of brain cancer; in Phase II clinical trials to treat thyroid cancer; and in Phase I/II clinical trials for the treatment of ovarian cancer, as well as VB-201, an oral small molecule that is in Phase II clinical trials for the treatment psoriasis and ulcerative colitis. The company was formerly known as Medicard Ltd. and changed its name to Vascular Biogenics Ltd. in January 2003. Vascular Biogenics Ltd. was founded in 2000 and is headquartered in Or Yehuda, Israel.
Medicine Biotechnology Health Biopharmaceutical Cancer Medical Specialties Pharmaceutical Industry Autoimmune Diseases Clinical Trial Ovarian Cancer Psoriasis Ulcerative Colitis Treatment Of Ovarian Cancer Brain Cancer Recurrent Glioblastoma Thyroid Cancer
Is VBLT a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 3.1
52 Week Low 0.6
Average Volume 115,866
200-Day Moving Average 1.3886
50-Day Moving Average 1.4056
20-Day Moving Average 1.2694
10-Day Moving Average 1.26
Average True Range 0.0775
ADX 14.42
+DI 19.3691
-DI 13.8535
Chandelier Exit (Long, 3 ATRs ) 1.1775
Chandelier Exit (Short, 3 ATRs ) 1.4325
Upper Bollinger Band 1.3398
Lower Bollinger Band 1.199
Percent B (%b) 0.58
BandWidth 11.091854
MACD Line -0.0295
MACD Signal Line -0.043
MACD Histogram 0.0135
Fundamentals Value
Market Cap 34.57 Million
Num Shares 27 Million
EPS -0.67
Price-to-Earnings (P/E) Ratio -1.91
Price-to-Sales 0.00
Price-to-Book 4.70
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.42
Resistance 3 (R3) 1.42 1.37 1.39
Resistance 2 (R2) 1.37 1.34 1.37 1.38
Resistance 1 (R1) 1.33 1.32 1.31 1.33 1.38
Pivot Point 1.28 1.28 1.27 1.28 1.28
Support 1 (S1) 1.24 1.25 1.22 1.24 1.18
Support 2 (S2) 1.19 1.23 1.19 1.18
Support 3 (S3) 1.15 1.19 1.17
Support 4 (S4) 1.15